After AGV implantation , 47 cases ( group 1 ) received topical timolol-dorzolamide fixed-combination drops twice daily when intraocular pressure ( IOP ) exceeded 10 mmHg , whereas 47 controls ( group 2 ) received conventional stepwise treatment when IOP exceeded target pressure .